Yantai Lannacheng Biotechnology Co., Ltd.
PrivateLast Round
Series C
Jul 18, 2025
Est. Valuation
$459.14M
Total Funding Raised
$164.52M
Company Overview
Yantai Lannacheng Biotechnology Co., Ltd. is a clinical-stage biotechnology company that develops radiopharmaceuticals for integrated cancer diagnosis and therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yantai Lannacheng Biotechnology Co., Ltd. Comparables
Compare Yantai Lannacheng Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Full-Life Technologies | 85% | |
| Suzhou SmartNuclide Biopharmaceutical Co., Ltd. | 82% | |
| Chengdu NewRT Medical Technology | 82% |
Yantai Lannacheng Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 18, 2025 | ||||
| Series C | Feb 14, 2025 | ||||
| Series B Extension | Apr 25, 2024 | ||||
| Series B | Jun 27, 2023 | ||||
| Series A | Jun 8, 2022 |
Yantai Lannacheng Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Cinda | Series C |
| 烟台财金集团 | Series B Extension |
| 山东省新动能基金管理有限公司 | Series C |
| Real Power Capital | Series C |
| Qianhai Fund of Funds | Series B Extension |
| Shenzhen Capital Group | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2025
$68M round with participation from China Cinda and Real Power Capital.
- Feb 14, 2025
Raised $21M with Yantai Dongcheng Pharmaceutical Group participating.
Yantai Lannacheng Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Yantai Lannacheng Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Yantai Lannacheng Biotechnology Co., Ltd. a public or private company?
Yantai Lannacheng Biotechnology Co., Ltd. is a private company.
What is the current stock price of Yantai Lannacheng Biotechnology Co., Ltd.?
Yantai Lannacheng Biotechnology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Yantai Lannacheng Biotechnology Co., Ltd. worth (valuation)?
Yantai Lannacheng Biotechnology Co., Ltd.'s valuation is estimated at $459.1M based on funding round data.
Can I buy Yantai Lannacheng Biotechnology Co., Ltd. stock?
Yantai Lannacheng Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Yantai Lannacheng Biotechnology Co., Ltd.'s last funding round?
Yantai Lannacheng Biotechnology Co., Ltd.'s most recent funding round was Series C on July 18, 2025.
Who are the main investors in Yantai Lannacheng Biotechnology Co., Ltd.?
Key investors in Yantai Lannacheng Biotechnology Co., Ltd. include Shenzhen Capital Group.
Will Yantai Lannacheng Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Yantai Lannacheng Biotechnology Co., Ltd..
How can I track Yantai Lannacheng Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Yantai Lannacheng Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.